CurrentCardio
Get Weekly

CurrentCardio coverage · page 7 of 17

JACC

Briefs 241–280 of 680 CurrentCardio has covered from this journal, newest publication first

Latest from JACC

All coverage, newest first

  1. J Am Coll Cardiol

    Sex Differences in Effectiveness of Semaglutide in Patients With Peripheral Artery Disease: The STRIDE Trial

    Secondary analysisAortic & peripheral

  2. J Am Coll Cardiol

    Computed Tomography Angiography or Standard Care After Left Main PCI?

    Randomised controlled trialCoronary & ACS

  3. J Am Coll Cardiol

    Twice-Daily Clopidogrel vs Ticagrelor to Reduce Short-Term Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention: The TADCLOT Trial

    Randomised controlled trialCoronary & ACS

  4. J Am Coll Cardiol

    Personalized or Standard Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: The PARTHENOPE Randomized Trial

    Randomised controlled trialCoronary & ACS

  5. J Am Coll Cardiol

    Pharmacologic Treatment of Heart Failure With Reduced Ejection Fraction: An Updated Systematic Review and Network Meta-Analysis

    Meta-analysisHeart failure

  6. J Am Coll Cardiol

    Colchicine and Longitudinal Dynamics of Clonal Hematopoiesis: An Exploratory Substudy of the LoDoCo2 Trial

    Secondary analysisCoronary & ACS

  7. J Am Coll Cardiol

    Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology

    Guideline or statementHypertension

  8. J Am Coll Cardiol

    Causes of Myocardial Infarction in Younger Patients: Troponin-Elevation in Persons ≤65 Years Old in Olmsted County

    Cohort studyCoronary & ACS

  9. J Am Coll Cardiol

    Outcomes of Percutaneous Mechanical Aspiration in Right-Sided Infective Endocarditis: A Multicenter Registry

    Cohort studyCardio-oncology & other

  10. J Am Coll Cardiol

    A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular Risk

    Cohort studyHeart failure

  11. J Am Coll Cardiol

    Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy: Exploratory Insights From the ODYSSEY-HCM Trial

    Secondary analysisHeart failure

  12. J Am Coll Cardiol

    Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease: Pooled Participant-Level Analysis of 3 Global Trials

    Meta-analysisCardiometabolic & kidney

  13. J Am Coll Cardiol

    Effects of Mavacamten on Cardiac Biomarkers in Nonobstructive Hypertrophic Cardiomyopathy: Insights From the ODYSSEY-HCM Trial

    Secondary analysisHeart failure

  14. J Am Coll Cardiol

    Effect of Vericiguat on Total Heart Failure Events in Compensated Outpatients With HFrEF: Insights From VICTOR

    Secondary analysisHeart failure

  15. J Am Coll Cardiol

    Trade-Off Between Bleeding and Ischemic Events From Left Ventricular Assist Devices: A EUROMACS Registry Analysis

    Cohort studyHeart failure

  16. J Am Coll Cardiol

    Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients

    Meta-analysis

  17. J Am Coll Cardiol

    Natriuretic Peptides, Body Mass Index, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

    Meta-analysisHeart failure

  18. J Am Coll Cardiol

    Adiposity-Related Anthropometrics and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Participant-Level Pooled Analysis of Randomized Clinical Trials

    Meta-analysisHeart failure

  19. J Am Coll Cardiol

    Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women

    Cohort studyPrevention & lipids

  20. J Am Coll Cardiol

    Effect of Aficamten Compared With Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM

    Secondary analysisHeart failure

  21. J Am Coll Cardiol

    Clinical Outcomes of Conduction System Pacing vs Right Ventricular Septal Pacing in Atrioventricular Block: The CSPACE Randomized Controlled Trial

    Randomised controlled trialArrhythmias & EP

  22. J Am Coll Cardiol

    Evidentiary Landscape of Heart Failure Therapies, Regulatory Decisions, and Translation Into Guidelines

    Research articleHeart failure

  23. J Am Coll Cardiol

    Long-Term Outcomes After Fractional Flow Reserve vs Intravascular Ultrasound to Guide PCI: The FLAVOUR Trial Extended Follow-Up

    Randomised controlled trialCoronary & ACS

  24. J Am Coll Cardiol

    Paclitaxel-Coated Balloon for the Treatment of Multilayer In-Stent Restenosis: AGENT IDE Subgroup Analysis

    Secondary analysisCoronary & ACS

  25. J Am Coll Cardiol

    Pop-Up Cardiovascular Screening Within Community Pharmacies and an International Sporting Event

    Cohort studyPrevention & lipids

  26. J Am Coll Cardiol

    2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

    Guideline or statementHypertension

  27. J Am Coll Cardiol

    Effects of Vutrisiran on Cardiac Function and Outcomes in Patients With Transthyretin Amyloidosis With Cardiomyopathy

    Secondary analysisHeart failure

  28. J Am Coll Cardiol

    Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF Substudy

    Meta-analysisArrhythmias & EP

  29. J Am Coll Cardiol

    Using Compression Stockings to Prevent Recurrence of Vasovagal Syncope: A Randomized Sham-Controlled Trial

    Randomised controlled trialArrhythmias & EP

  30. J Am Coll Cardiol

    Effect of HEPA Filtration Air Purifiers on Blood Pressure: A Pragmatic Randomized Crossover Trial

    Randomised controlled trialHypertension

  31. J Am Coll Cardiol

    Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection Fraction

    Cohort studyHeart failure

  32. J Am Coll Cardiol

    Optimizing the Primary Prevention of Sudden Cardiac Death in Patients With Heart Failure

    Research articleHeart failure

  33. J Am Coll Cardiol

    Sodium-Glucose Cotransporter 2 Inhibitor With and Without an Aldosterone Antagonist for Heart Failure With Preserved Ejection Fraction: The SOGALDI-PEF Trial

    Randomised controlled trialHeart failure

  34. J Am Coll Cardiol

    Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of Tirzepatide in HFpEF: The SUMMIT Trial

    Secondary analysisHeart failure

  35. J Am Coll Cardiol

    AHA PREVENT Equations and Cardiovascular Disease Risk in Diverse Health Care Populations

    Cohort studyPrevention & lipids

  36. J Am Coll Cardiol

    Global Impact of Fixed-Dose Combination Therapies on Cardiovascular Mortality and Events, 2023-2050: A Modeling Study

    Research articlePrevention & lipids

  37. J Am Coll Cardiol

    The Global Syndemic of Modifiable Cardiovascular Risk Factors Projected From 2025 to 2050

    Research articlePrevention & lipids

  38. J Am Coll Cardiol

    Plaque Vulnerability and Cardiovascular Risk Factor Burden in Acute Coronary Syndrome: An Optical Coherence Tomography Analysis

    Cross-sectional studyCoronary & ACS

  39. J Am Coll Cardiol

    3-Year Clinical Outcomes Comparing the Amulet vs Watchman FLX for Left Atrial Appendage Closure in Patients With Atrial Fibrillation: Results From the SWISS-APERO Randomized Clinical Trial

    Randomised controlled trialValvular & structural

  40. J Am Coll Cardiol

    Catheter Ablation vs Lifestyle Modification With Antiarrhythmic Drugs to Treat Atrial Fibrillation: PRAGUE-25 Trial

    Randomised controlled trialArrhythmias & EP

All 680 Briefs in ExploreShowing Briefs 241–280 of 680, newest first